Spyre Therapeutics (SYRE) Tax Rate (2021 - 2025)

Spyre Therapeutics has reported Tax Rate for 5 years, with the latest figure at 0.03% in Q1 2025.

• For the quarter ending Q1 2025, Tax Rate rose 11.0% year-over-year to 0.03%; the trailing twelve-month figure through Dec 2025 stood at 0.01% (up 3.0% YoY), and the FY2025 full-year result was 0.01%, up 3.0% from the prior year.
• Tax Rate for Q1 2025 stood at 0.03%, up from 0.0% in the prior quarter.
• The five-year high for Tax Rate was 1.13% in Q3 2022, with the low at 1.37% in Q2 2021.
• Historically, Tax Rate has averaged 0.05% across 5 years, with a median of 0.03% in 2024.
• Annual changes were most pronounced in 2022 — Tax Rate soared 133 bps — and 2023, when it sank 114 bps.
• Spyre Therapeutics' Tax Rate stood at 0.11% in 2021, then sank by 80 bps to 0.2% in 2022, then surged by 96 bps to 0.01% in 2023, then jumped by 76 bps to 0.0% in 2024, then surged by 1985 bps to 0.03% in 2025.
• The last three Tax Rate figures came in at 0.03% (Q1 2025), 0.0% (Q4 2024), and 0.03% (Q3 2024), per Business Quant data.